Option Care Health, Inc. $OPCH Shares Bought by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC raised its position in Option Care Health, Inc. (NASDAQ:OPCH) by 4.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,561,015 shares of the company’s stock after acquiring an additional 60,029 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.95% of Option Care Health worth $49,874,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of OPCH. Durable Capital Partners LP acquired a new stake in Option Care Health in the first quarter valued at approximately $122,905,000. Nuveen LLC acquired a new stake in shares of Option Care Health during the first quarter worth approximately $70,965,000. Fuller & Thaler Asset Management Inc. grew its position in shares of Option Care Health by 30.8% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after buying an additional 989,048 shares in the last quarter. Boston Partners acquired a new stake in shares of Option Care Health during the first quarter worth approximately $24,353,000. Finally, Assenagon Asset Management S.A. grew its position in shares of Option Care Health by 227.1% during the second quarter. Assenagon Asset Management S.A. now owns 635,758 shares of the company’s stock worth $20,649,000 after buying an additional 441,417 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

OPCH has been the subject of a number of recent analyst reports. JMP Securities raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. Barrington Research restated an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research note on Tuesday, September 23rd. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Wednesday, October 8th. Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Cowen started coverage on Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating on the stock. Eight research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.11.

Insider Buying and Selling

In other news, Director Norman L. Wright bought 3,411 shares of the stock in a transaction that occurred on Tuesday, September 9th. The shares were purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the acquisition, the director directly owned 15,501 shares in the company, valued at approximately $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was bought at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the purchase, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This represents a 10.61% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 59,411 shares of company stock valued at $1,627,576 over the last three months. Company insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

OPCH stock opened at $27.10 on Wednesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a market capitalization of $4.40 billion, a price-to-earnings ratio of 21.68, a PEG ratio of 1.62 and a beta of 0.88. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The stock’s fifty day moving average is $28.05 and its two-hundred day moving average is $30.43.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same period in the previous year, the business earned $0.30 earnings per share. The company’s revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.